Skip to main content
. Author manuscript; available in PMC: 2010 May 17.
Published in final edited form as: Antivir Ther. 2008;13(3):423–428.

Table 1.

Characteristics of the participants

Age (years, mean±SD) 49±6

Body Mass index (kg/m2, mean±SD) 28.1±2.9

Race: % Caucascian: Latin/Hispanic: African American 48:47:5
CD4 count (cells/ml, median) 510
HIV viral load (% undetectable) 74
Current antiretroviral therapy (%)
 HAART 100%
 Protease inhibitor 57
 Nucleoside reverse transcriptase inhibitor 100
 Non-nucleoside reverse transcriptase inhibitor 35
Hepatitis C co-infection (%) 22